PROMISES FOR TREATING COLON CANCER PATIENTS WITH BRAF GENE MUTATION

Colon cancer represents a heterogenous disease group, which differ by cancerogenesis mechanisms, molecular alterations, prognosis and treatment possibilities. In modern clinical practice assessment of KRAS and NRAS genes status is already necessary in order to prescribe anti-EGFR treatment for metas...

詳細記述

書誌詳細
出版年:Тазовая хирургия и онкология
主要な著者: M. Yu. Fedyanin, A. A. Tryakin, S. A. Tjulandin
フォーマット: 論文
言語:ロシア語
出版事項: “ABV-press” Publishing house”, LLC 2015-02-01
主題:
オンライン・アクセス:https://ok.abvpress.ru/jour/article/view/34